KUNMING, China, April 2, 2008 /Xinhua-PRNewswire-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (Amex: KUN) ("China Shenghuo" or "the Company"), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and cosmetic products in the People's Republic of China ("PRC"), today announced that it will present at the upcoming Brean Murray Carret & Co. Mainland China Investor Tour to be held at Grand Hyatt Shanghai on April 4, 2008.
The Brean Murray Carret & Co. Mainland China Investor Tour is a
five-day event featuring presentations from 67 U.S.-listed Chinese
companies from a number of sectors, such as technology, healthcare, energy,
industrial and consumer products.
Date: Friday, April 4, 2008
Time: 9:00 a.m. Beijing time
Venue: The Grand Hyatt Shanghai, 88 Century Blvd.,
Jin Mao Tower, Shanghai
Participation in the Brean Murray Carret & Co. Mainland China Investor Tour is by invitation only. Further information can be found at http://www.breanmurraycarret.com .
About China Shenghuo Pharmaceutical Holdings, Inc.
Founded in 1995, China Shenghuo Pharmaceutical Holdings, Inc. ("China
Shenghuo" or "the "Company") is a specialty pharmaceutical company that
focuses on the research, development, production and marketing of
Sanchi-based medicinal products. Through its subsidiary, Kunming Shenghuo
Pharmaceutical (Group) Co., Ltd. ("Kunming Shenghuo"), it owns twenty-eight
SFDA (State Food and Drug Administration)-approved medicines, including the
flagship product Xuesaitong Soft Capsules, which has already been listed in
the Insurance Catalogue. At present, China Shenghuo incorporates a sales
network of agencies and representatives throughout China, which markets
Sanchi-based traditional Chinese medicine to hospitals and drug stores as
prescription and OTC drugs primarily for the treatment of cardiovascular,
cerebrovascular and peptic ulcer disease. The Company also exports
medicinal products to Asian countries such as Indonesia, Russia and
Kyrgyzstan. For more information, please visit http://www.shenghuo.com.cn .
For more information, please contact:
China Shenghuo Pharmaceutical Holdings, Inc.
Ms. Gao Qionghua, CFO
CCG Elite Investor Relations
Crocker Coulson, President
Tel: +1-646-213-1915 (New York)
|SOURCE China Shenghuo Pharmaceutical Holdings, Inc.|
Copyright©2008 PR Newswire.
All rights reserved